论文部分内容阅读
目的:分析探讨在小儿支气管肺炎治疗中,头孢曲松钠联合痰热清注射液治疗的临床疗效。方法:选取76例支气管肺炎患儿随机均分为对照组与观察组,两组各38例,对照组给予单纯头孢曲松钠治疗,观察组给予头孢曲松钠+痰热清注射液治疗,比较两组患儿治疗后的疗效。结果:观察组患儿总有效率97.4%,显著高于对照组92.1%(P<0.05);观察组患儿治疗后体温恢复时间、临床症状消失时间、肺部体征消失时间与住院时间,血清中性粒细胞比较显著优于对照组(P<0.05)。结论:在小儿支气管肺炎治疗中,头孢曲松钠联合痰热清注射液治疗的临床疗效更加显著,并且安全可靠,无明显不良反应,具有临床推广与应用的价值。
Objective: To analyze the clinical efficacy of ceftriaxone sodium combined with Tanreqing Injection in the treatment of pediatric bronchial pneumonia. Methods: A total of 76 children with bronchial pneumonia were randomly divided into control group and observation group, with 38 cases in each group. The control group was treated with ceftriaxone sodium alone. The observation group was treated with ceftriaxone sodium and Tanreqing Injection. The curative effect of the two groups was compared. Results: The total effective rate in observation group was 97.4%, which was significantly higher than that in control group (92.1%, P <0.05). The recovery time of body temperature, the disappearance of clinical symptoms, the disappearance time of lung signs and hospital stay, Neutrophils were significantly better than the control group (P <0.05). Conclusion: In the treatment of children with bronchial pneumonia, ceftriaxone sodium combined with Tanreqing injection treatment more significant clinical efficacy, and safe and reliable, no obvious adverse reactions, with clinical application and promotion of the value.